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Introduction: Gastrointestinal recovery describes the restoration of normal bowel function in 
patients with bowel disease. This may be prolonged in two common clinical settings: 
postoperative ileus and small bowel obstruction. Improving gastrointestinal recovery is a 
research priority but researchers are limited by variation in outcome reporting across clinical 
studies. This protocol describes the development of core outcome sets for gastrointestinal 
recovery in the contexts of postoperative ileus and small bowel obstruction.  
Methods: An international Steering Group consisting of patient and clinician representatives 
was established. As overlap between clinical contexts is anticipated, both outcome sets will 
be co-developed and may be combined to form a common output with disease-specific 
domains. The development process will comprise three phases, including definition of 
outcomes relevant to postoperative ileus and small bowel obstruction from systematic 
literature reviews and nominal-group stakeholder discussions; online-facilitated Delphi surveys 
via international networks; and a consensus meeting to ratify the final output. A nested study 
will explore if the development of overlapping outcome sets can be rationalised.  
Dissemination and implementation: The final output will be registered with the COMET 
initiative. A multi-faceted, quality improvement campaign for the reporting of gastrointestinal 
recovery in clinical studies will be launched, targeting international professional and patient 
groups, charitable organisations, and editorial committees. Success will be explored via an 







Gastrointestinal recovery describes the restoration of normal bowel function in patients 
receiving treatment for bowel disease. This may be prolonged in two settings. The first is 
postoperative ileus, characterised by reduced or uncoordinated intestinal transit. This occurs 
in 10-20% of patients undergoing major gastrointestinal surgery, depending on the criteria 
used for assessment (1). The second is small bowel obstruction, characterised by intestinal 
blockage. This is responsible for half of all emergency laparotomies in the United Kingdom and 
over 300,000 hospital admissions per year in North America (2, 3). Whilst both represent 
different aetiologies, the clinical manifestations of gastrointestinal recovery are similar.  
Delayed gastrointestinal recovery is distressing for patients. It leads to painful abdominal 
distension, vomiting, delayed elimination, and prolonged hospital stay. It may also implicate 
the need for nasogastric decompression. The Association of Coloproctology in Great Britain & 
Ireland recently identified gastrointestinal recovery as a key research priority during a patient-
clinician consensus process (4). Researchers are limited, however, by methodological 
challenges related to the definition of normal gastrointestinal function and the selection of 
clinical outcomes (5). Recently, two systematic reviews of previous literature identified 73 and 
50 outcomes used to measure gastrointestinal recovery in settings of ileus and small bowel 
obstruction, respectively (6, 7). This wide variation in reporting limits comparability between 
studies, and is problematic for evaluating new treatments and translating these into practice.  
The COMET (Core Outcome Measures in Effectiveness Trials) Initiative aims to develop ‘core 
outcome sets’ which represent the minimum information to be reported in all studies of a clinical 
condition (8). Currently, no such core outcome set exists for gastrointestinal recovery in either 
context of ileus or small bowel obstruction This would increase the value of future research 
through consistent and systematic reporting of results. As there is considerable overlap in the 
features of gastrointestinal recovery between both conditions, co-development of two outcome 
sets with the scope to combine or segment condition-specific domains represents an efficient 
approach. A protocol, analysis plan, and impact strategy are herein described.  
Methods 
This study protocol is reported with consideration to the Core Outcome Set-STAndards for 
Development (COS-STAD) recommendations and the Core Outcome Measures in 
Effectiveness Trials (COMET) handbook (8, 9). The final core outcome set will be reported 
according to the COS-STAndards for Reporting Statement (10). Research ethics approval will 
be confirmed in advance of all fieldwork and individual participant consent will be sought.  
Scope 
We aim to establish global consensus amongst patients, carers, academics, and clinicians on 
a minimal set of outcomes for gastrointestinal recovery in contexts of ileus after gastrointestinal 
surgery, and small bowel obstruction not requiring surgery. Both conditions represent different 
clinical contexts, but both share common challenges related to gastrointestinal recovery.  We 
consider gastrointestinal surgery to represent any abdominal procedure performed on the 
intestinal tract, from the oesophagus (below the diaphragm) through to the anus. Other 
abdominal procedures (such as vascular, urological, and gynaecological) are excluded since 
unique speciality- and disease-specific outcomes may apply.  
Steering Group 
An international, patient-clinician steering group has been established with representation from 
four geographical areas (Asia, Australasia, Europe, and America). Expert representatives have 
insights into the challenges of study design and outcome selection. Patient representatives 
have insights into the clinical and social implications of gastrointestinal recovery and will ensure 
that the patient perspective remains prominent throughout. All members of the steering group 
will be involved in the planning, execution, and dissemination of the final core outcome set.  
Stakeholders  
Patients and healthcare professionals will contribute equally to the development of the final 
core outcome set. To maximise generalisability and capture diverse viewpoints, contributions 
will be invited across a wide international setting, including (but not limited to) countries in Asia, 
Australasia, Europe, and North America. Patient and carer contributions will be invited from 
individuals with personal insights into ileus or small bowel obstruction. Professional 
contributions will be invited from individuals with expert insights into gastrointestinal recovery. 
This will include clinicians (gastrointestinal surgeons, anaesthesiologists, intensivists, and 
gastroenterologists), nurses (including nurse specialists such as stoma and enhanced 
recovery nurses), and allied healthcare professionals (dieticians and physiotherapists).  
Study Design 
The development of two outcome sets for gastrointestinal recovery (ileus and small bowel 
obstruction) will begin in parallel. Due to similarities between both clinical contexts, common 
domains may emerge and may justify the development of a modular outcome set. Decisions 
on the final structure will be informed through iterative review of emerging data. The 
development process will comprise three phases (Figure 1). In the first phase, outcomes 
identified from systematic reviews will be longlisted, followed by further additions during a 
series of nominal-group discussions. The second phase will consist of a three-round, online 
Delphi survey disseminated via international networks. In the third phase, a face-to-face 
stakeholder consensus meeting will be convened for voting on the final eligibility of short-listed 
outcomes. The study will be followed by a quality improvement campaign to disseminate and 
implement the final outcome set across stakeholder communities. 
Longlisting of Outcomes 
A longlist of outcomes reported in previous studies of ileus and small bowel obstruction will be 
compiled from two recent systematic reviews (6, 7). Further longlisting will take place via 
patient-clinician discussions (using nominal group technique) during a series of international 
study meetings. These will be small gatherings (<10 individuals) convened jointly by video 
conference and local members of the Steering Group. A single meeting will take place for each 
geographical area (Asia, Australasia, Europe, and North America) to maximise the study’s 
applicability. Additional outcomes generated during small group discussions will be added to 
produce two final longlists of outcomes for ileus and small bowel obstruction, respectively.  
Delphi Survey  
Individuals from all stakeholder groups will be invited to participate in a three-round, online-
facilitated, international Delphi survey using the Google Forms platform. All surveys will be 
conducted in English. During the first round, surveys for ileus and small bowel obstruction will 
run in parallel and participants will be offered the opportunity to complete one or both; 
subsequent invitations will be issued according to this pre-specified preference. Invitations will 
be disseminated via professional societies, social media platforms, patient support groups, 
international collaborators, and charitable organisations. Consent to participate will be 
confirmed prior to completion of the first survey. Participants may offer novel outcomes via an 
open-ended question during the first Delphi round for incorporation into subsequent rounds of 
voting. Feedback on the process will also be sought. Participants who complete all Delphi 
rounds will be offered collaborative co-contributorship of the final output.  
During each round, longlisted outcomes will appear in a random order. They will be linked to a 
plain English summary which will be co-authored and piloted by patient members of the 
Steering Group. In each round, participants will score outcomes using a Likert scale of 1-9, as 
recommended by the Grading of Recommendations Assessment, Development and 
Evaluation working group and COMET initiative (8, 11).  Scores of 1-3 will indicate an outcome 
of ‘little importance’, 4-6 will indicate ‘some importance’, and 7-9 will indicate ‘great 
importance’.  
During Round 1, scores will be analysed within each stakeholder group (patients, clinicians, 
nurses, and allied healthcare professionals). Consensus for short-listing of outcomes will be 
defined according to the following criteria.  
• Greater than 70% of participants in at least one stakeholder group scoring the outcome 
as 7–9 and less than 15% in at least one group scoring the outcome as 1–3. 
Responses will be collected across a period of 8 weeks. The Steering Committee will meet to 
discuss the inclusion of additional outcomes and rewording of survey components if 
misinterpretation is suspected from feedback. The results of both surveys (ileus and small 
bowel obstruction) will also be discussed; sufficient similarities in scoring may justify the 
development of a common outcome set with modules relating to specific clinical domains.  
During Rounds 2 and 3, participants’ previous responses, as well as a summary of stakeholder-
specific scores from previous rounds will be presented. Only participants who contributed to 
the first round of surveys will be invited to participate in subsequent rounds. Participants will 
be asked to re-score all outcomes which have not yet met the criteria for short-listing. The 
same criteria for consensus will be applied across all rounds. All outcomes that reach 
consensus after three rounds will enter the short-list and will be considered at the consensus 
meeting. They will be considered together with items where split-voting, misinterpretation of 
language, or marked heterogeneity in panel prioritisation is noted by the Steering Group.  
Consensus Meeting 
Through a process of maximum variation purposive sampling, 10 representatives from each 
stakeholder group will be invited to a consensus event and asked to vote on the inclusion and 
exclusion of short-listed outcomes. This will be held at an international academic conference 
where attendance of all relevant stakeholders is anticipated. Representatives from journal 
editorial committees, industry, and surgical interest groups will also be invited as observers to 
provide comments on the final outcome set and its future implementation. Three rounds of 
voting with interactive discussion will be facilitated. Outcomes that exceed a pre-determined 
threshold of agreement (70%) will enter the final outcome set.  
Final Core Outcome Set development 
It is envisaged that the final outcome set will consist of no more than 10 potential outcomes. 
Whilst there is no recommended maximum, a rational outcome set is desirable to facilitate 
implementation. Each of the accepted outcomes will be categorised according to areas of the 
OMERACT filter (life impact; resource use; pathophysiological manifestations; and death) (12).  
Based on review of all data, the Steering Committee will decide on recommendations for the 
final structure; this may comprise two discrete core outcome sets for ileus and small bowel 
obstruction, or a common modular outcome set with domains relevant to both clinical contexts.  
Attrition and Sample Size 
It is anticipated that some participants will drop out from each round of the Delphi survey. Each 
participant will be allocated a unique identification number to allow tracking and identification 
of responses. The Steering Group will monitor trends in attrition (such as stakeholder group 
and geographical region) between rounds and consider strategies to maximise the response 
rates. There are no formal recommendations to guide sample size calculation for a Delphi 
survey, but a target of 100 international participants per stakeholder group will be sought. 
Recruitment to the first Delphi round will begin 8 weeks prior to the surveys opening for 
responses and no further participants will be included once the first round closes.      
Dissemination and Implementation 
The final outcome set will be registered with the COMET initiative. A quality improvement 
campaign for the reporting of gastrointestinal recovery in academic literature will launch. This 
will involve presentations to academic audiences, lobbying of journal editorial teams, and 
promotion to professional organisations. Open-access plain English summaries will be 
disseminated to relevant patient and public groups. It is anticipated that uptake of the final 
output will be gradual. Success will be explored via an updated systematic review of outcomes 
five years after registration of the core outcome set. A 25% reduction in uniquely reported 
outcomes will represent a meaningful improvement.  
Nested Methodological Study  
As this study considers two clinical conditions with substantial overlap, a design modification 
to improve the efficiency of core outcome set development will be explored. This will involve 
Principal Component Analysis (PCA), a process which uses factor analysis to reduce the 
number of items in a list into themes measuring similar ideas or constructs (13). It achieves 
this by looking at the correlation of items across respondents and the behaviours of groups of 
items. In the present setting, PCA will be applied to both Delphi surveys (ileus and small bowel 
obstruction) after the conclusion of Round 1. Where components with similar constituent items 
are seen across both surveys, they will be merged for Round 2 and scored in combination. By 
measuring internal consistency of merged components, it may be possible to identify items 
with a high probability of exclusion. In the future, this may help participants to reduce the 
number of items within each domain more rapidly to produce a more consistent development 
process. A full description of these methods is outlined in Suppl. File 1 (14, 15).  














Delayed gastrointestinal recovery in the context of ileus after intestinal surgery and small bowel 
obstruction is distressing for patients and costly for healthcare systems. Although the 
development of a core outcome set for gastrointestinal recovery will not lead to immediate 
changes to clinical care, it should lead to improved reporting of outcomes in the published 
literature. This will facilitate more valid comparisons of new treatments, helping to expedite 
improvements in the care offered to patients with these conditions. Importantly, the role of a 
core outcome set is to determine which outcomes are most relevant, as guided by a panel of 
key stakeholders. It should not command which outcome is most appropriate for calculating 
sample size, and neither can it guide how individual outcomes should be measured. Further 
research to refine these questions in the context of gastrointestinal recovery will be necessary.  
The efficient development of a core outcome set for two clinical contexts is a strength of this 
study. Although ileus after gastrointestinal surgery and small bowel obstruction represent 
different clinical contexts, the challenges of gastrointestinal recovery between both are similar. 
An efficient and practical design may help with implementation of the final outcome set and is 
beneficial for avoiding research waste and duplication. Another strength of this study is the 
support from international and diverse stakeholders. Contributions from patients and carers 
ensures that the eventual outcome set remains patient-centred; support from multiple allied 
disciplines ensures that the outcome set is relevant to multidisciplinary practice; and 
involvement from collaborators from diverse geographical regions (including low-middle 
developed countries) ensures that it is widely generalisable.  
Challenges in the study design are also recognised. Firstly, response rates for individual 
stakeholder groups in the Delphi surveys is a key challenge when facilitating the study online. 
It is possible that a disproportionate number of clinicians may respond to the survey, but this 
will be mitigated by working closely with patient support groups, charitable organisations, and 
patient members of the Steering Group. It is hoped that a balanced number of patient and 
carer contributions will be gathered to ensure that the process is patient-focussed throughout. 
Likewise, the Steering Group will ensure that the views of the patient stakeholder group are 
always accorded priority. Secondly, the scope of the study is limited to gastrointestinal recovery 
within the context of gastrointestinal disease, which does not account for other types of 
abdominal surgery where ileus is also problematic. This includes vascular, gynaecological, 
orthopaedic, cardiac, and urological procedures. This is necessary since is it possible that 
unique, disease-specific outcomes may apply to these patient groups but would not be 
captured from the current cohort of stakeholders. Finally, achieving wide implementation of a 
core outcome set is challenging and time consuming. This is a gradual process requiring 
extensive support from academic leaders and influencing bodies. A prospective impact and 
dissemination plan is presented and will ensure that issues of implementation are considered 
throughout. Measurable criteria for determining success of implementation will help to track 
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Figure 1: Study schema:  
 
Phase 1: Finalisation of long list; Phase 2: three-round Delphi survey; Phase 3: Consensus 
meeting to finalise the outcome set. The study will be followed by a dedicated quality 











Suppl. File 1: Nested methodological study 
Principal Component Analysis to develop cross-readable frameworks 
PCA is a form of exploratory factor analysis looking at a dataset and identifying associations 
and underlying constructs (13). Specifically, PCA is useful for reducing a longlist of items into 
a shortlist made up of newly generated components reflecting their latent constructs (14). It 
achieves this by looking at the correlation of items across respondents and the behaviours of 
groups of items. In the present study, for example, the ratings of ‘time to first flatus’, ‘time to 
tolerate oral diet’, and ‘time to resolution of nausea’ may demonstrate similar behaviours. PCA 
will identify this cluster as a ‘component’. Where components with similar constituent items and 
characteristics are seen across both surveys in Round 1, they will be merged for Round 2. 
Subsequent scoring will then take place on a combined set of items for a single construct. This 
may help participants to reduce the number of items for each domain more rapidly, and with 
consistency across diseases which show significant clinical similarity.  
Identification items with high probability of exclusion 
Following the PCA, it is possible to assess the internal consistency of each component. This 
is achieved by calculating Cronbach’s alpha for each construct, as well as the corrected item 
correlation. Items with a corrected item correlation of <0.5 show low consistency and would 
typically be removed from a construct in PCA. These items will not be removed from the initial 
pool in this study, but it is hypothesised that these will not be included in the final round of 
voting. Additionally, some items may not be included in components identified through PCA. It 
is also hypothesised that these items may not be included in the final round of voting.  
Exploratory factor analysis 
PCA of the importance of factors to decision making will be conducted using SPSS version 24 
(IBM, Armonk, NY). Initially, the dataset for round one voting will be checked for adequacy of 
sampling using the Kaiser-Meyer-Olkin test. The dataset will be checked for sphericity 
(whether it contains sufficient variation to permit PCA) using Bartlett’s test. A correlation matrix 
will then be constructed. Communalities of factors will be assessed to identify and remove any 
factors with values of <0.6. PCA will be conducted using a varimax orthogonal rotation matrix. 
Factor reduction will be undertaken using the Eigenvalue method, where factors with 
Eigenvalue <1 are removed. The loading of remaining factors will be assessed. A loading value 
cut-off of 0.45 is selected as it is associated with ‘good’ discrimination between trivial and non-
trivial factors (15). The resulting factors and components will be assessed by the Steering 
Group for face validity of the construct. Where there is cross loading of a factor across two 
components, each component will be reviewed to identify the best fit for the factor.  
Inter-item correlation 
The internal consistency of each construct will be assessed using Cronbach’s alpha and the 
total item correlation (TIC) for each item within the construct. Items with TIC <0.5 will be 
identified. 
Association of item performance in round two with characteristics in round one 
The mean scores of items carried from round one to round two will be collated. Two tests will 
be performed using Mann-Whitney U test. The first test will assess item scores split into those 
with TIC <0.5 vs those with TIC ≥0.5. The second will assess the scores of items in identified 
categories vs those identified as orphan at round 1. Statistical significance will be set at p=0.05.  
Sample Size for Nested Methodological Study 
The supporting systematic reviews reported 73 outcomes for ileus after and 50 outcomes for 
small bowel obstruction. As the longlists are managed separately during Round 1 of the Delphi 
survey, they are considered separately for the purpose of calculating sample size. The longlist 
for ileus will inform calculations of sample size as it contains the greatest number of outcomes. 
The sample size for a PCA is based upon five responses per item; this means that a minimum 
of 365 complete responses is needed in order to undertake this analysis.  
 
